| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,686 | 67,732 | 60,566 | 58,331 | | Cost of Revenue | 9,109 | 8,811 | 8,548 | 9,717 | | | Gross Profit |
-
| 58,921 | 52,018 | 48,614 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 51,372 | 32,903 | 32,130 | 31,030 | | Non Recurring | (3,200) | 1,939 | 1,261 | 50,020 | | Others | 19,270 | 26,385 | 32,261 | 40,862 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (2,306) | (13,634) | (73,298) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (15,865) | (2,306) | (13,634) | (73,298) | | Interest Expense | 3,537 | 3,814 | 4,670 | 6,379 | | Income Before Tax | (19,402) | (6,120) | (18,304) | (79,677) | | Income Tax Expense | (1,088) | (959) | 293 | 10,348 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,314) | (5,161) | (18,597) | (90,025) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,314) | (5,161) | (18,597) | (90,025) | | Preferred Stock And Other Adjustments | (1,075) | (1,075) | (1,075) | (215) | | | Net Income Applicable To Common Shares | ($19,389) | ($6,236) | ($19,672) | ($90,240) |
|
0.17% Nasdaq 
Income Statement
